HPTLC determination of rabeprazole and domperidone in capsules and its validation.

This paper describes a validated high-performance thin-layer chromatography (HPTLC) method for simultaneous estimation of rabeprazole (RA) and domperidone (DO) in pure powder and in capsule formulations. An HPTLC method separation is achieved on an aluminum sheet of silica gel 60F(254) using ethyl acetate-methanol-benzene-acetonitrile (30:20:30:20 v/v) as mobile phase. Quantitation is achieved with UV detection at 287 nm over a concentration range of 400-1200 ng/spot and 600-1800 ng/spot with mean recovery of 99.82 +/- 0.74 and 99.43 +/- 0.68 for RA and DO, respectively, in the HPTLC method. This method is simple, precise, and sensitive, and it is applicable for the simultaneous determination of RA and DO in pure powder and in capsule formulation.

[1]  M. Patel,et al.  HPLC Analysis for Simultaneous Determination of Rabeprazole and Domperidone in Pharmaceutical Formulation , 2007 .

[2]  T. Habuchi,et al.  Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. , 2006, Journal of pharmaceutical and biomedical analysis.

[3]  A. Bhat,et al.  Reverse phase high performance liquid chromatographic determination of rabiprazole in tablet dosage form , 2006 .

[4]  Tarek Wahdan,et al.  "Determination of domperidone in tablet dosage form by anodic differential pulse voltammetry". , 2005, Farmaco.

[5]  N. Yasui-Furukori,et al.  Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  L. Rui,et al.  Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma. , 2005, Rapid communications in mass spectrometry : RCM.

[7]  A. Radi,et al.  Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form. , 2004, Farmaco.

[8]  M. Salem,et al.  Simultaneous determination of domperidone maleate and cinnarizine in a binary mixture using derivative ratio spectrophotometry and classical least squares calibration. , 2002, Journal of pharmaceutical and biomedical analysis.

[9]  M. J. Smit,et al.  Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of domperidone in human plasma. , 2002, Journal of chromatography. A.

[10]  M. Kobylińska,et al.  High-performance liquid chromatographic analysis for the determination of domperidone in human plasma. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[11]  Williams,et al.  Review article: the pharmacology of rabeprazole , 1999, Alimentary pharmacology & therapeutics.

[12]  A. Zavitsanos,et al.  Determination of domperidone in human serum and human breast milk by high-performance liquid chromatography-electrospray mass spectrometry. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[13]  A. Argekar,et al.  Simultaneous determination of cinnarizine and domepiridone maleate from tablet dosage form by reverse phase ion pair high performance liquid chromatography. , 1999, Journal of pharmaceutical and biomedical analysis.

[14]  H. Kotaki,et al.  Quantitative determination of domperidone in rat plasma by high-performance liquid chromatography with fluorescence detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[15]  S. S. Zarapkar,et al.  Simultaneous estimation of domperidone and omeprazole in pharmaceutical dosage by reverse phase high performance liquid chromatography , 2002 .

[16]  C. Vinodhini,et al.  Simultaneous estimation of cinnarizine and domperidone in solid oral dosage form using spectrophotometric method , 2002 .